REGULUS THERAPEUTICS INC's ticker is RGLS and the CUSIP is 75915K200. A total of 1 filers reported holding REGULUS THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 833 | -33.3% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 1,249 | +49.9% | 0.00% | – |
| Q1 2016 | $1,000 | – | 833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 5,074,251 | $1,598,000 | 3.34% |
| Asymmetry Capital Management, L.P. | 2,731,044 | $860,000 | 0.46% |
| DAFNA Capital Management LLC | 5,555,555 | $1,750,000 | 0.44% |
| Ikarian Capital, LLC | 1,228,416 | $388,000 | 0.06% |
| Sarissa Capital Management LP | 1,851,851 | $583,000 | 0.05% |
| NEA Management Company, LLC | 6,451,056 | $2,064,000 | 0.04% |
| WealthTrust Axiom LLC | 68,000 | $21,000 | 0.01% |
| GYL FINANCIAL SYNERGIES, LLC | 41,000 | $13,000 | 0.00% |
| All Terrain Financial Advisors, LLC | 15,000 | $5,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 124,056 | $39,000 | 0.00% |